Replies to post #71418 on Ariad Pharmaceuticals Inc fka ARIA

[biotech_researcher]

Virtually impossible to move into the $20's now as all of Ariad's compounds are wasting assets, except '788. Too much competition.

Harvey fooled Merck with Rida, and no firm will be fooled again with Ariad's marginalized assets.

[STOCKSEEK]

I agree with you Flex and likewise. Thanks for sharing your opinions.